Ignite Creation Date:
2024-05-05 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00479739
Status:
COMPLETED
Last Update Posted:
2016-09-15
First Post:
2007-05-25
Brief Title:
CONCEPT A 1-Year Comparison Of A Stable Dose Of SERETIDE Inhaler With An Adjustable Maintenance Dose Of SYMBICORT Inhaler SERETIDE Inhaler is a Trademark of GSK Group of Companies SYMBICORT Inhaler is a Trademark of Astra Zeneca
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-11
Start Date Type:
None
Primary Completion Date:
2004-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2004-07
Completion Date Type:
ACTUAL
First Submit Date:
2007-05-25
First Submit QC Date:
May 25 2007
Study First Post Date:
2007-05-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-09-13
Last Update Post Date:
2016-09-15
Last Update Post Date Type:
ESTIMATED